Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic ...

Gov. Andy Beshear and the Education and Labor Cabinet’s Division of Blind Services encourage Kentuckians to prioritize their ...

More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...

Aging brings wisdom, experience, and often, a host of changes — including those that affect our vision. "By the time most people reach their forties, the eye begins to undergo physiological ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...

Eye disorders such as cataracts and glaucoma fuel the sector’s demand. The rising prevalence of vision-related disorders is ...

An Editorial in The Lancet Neurology emphasised that rigorous prospective studies are essential to develop safe and ethical artificial intelligence (AI) tools for brain health.1 Yet, what usually ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...